Synapse - Works

Results (15763)

Addition of polatuzumab vedotin to bendamustine and rituximab (BR) improves outcomes in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) versus BR alone: Results from a randomized phase 2 study

Meeting Abstract

Sehn, L. H.; Herrera, A. F.; Matasar, M. J.; Kamdar, M.; McMillan, A. K.; Kim, T. M.; Kim, W. S.; Hertzberg, M.; Ozcan, M.; Penuel, E.; more...
Blood (2017)

Fulltext@MSK | Save

Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant

Meeting Abstract

Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
Blood (2017)

Fulltext@MSK | Save

Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen

Meeting Abstract

Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
Blood (2017)

Fulltext@MSK | Save

More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)

Meeting Abstract

Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
Blood (2017)

Fulltext@MSK | Save

Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: The largest multicenter retrospective analysis

Meeting Abstract

Mehta-Shah, N.; Teja, S.; Tao, Y.; Cashen, A. F.; Beaven, A.; Alpdogan, O.; Porcu, P.; Wiggin, M.; Song, K. W.; Alzahrani, M.; more...
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

Genome-wide association study for Waldenström macroglobulinemia identifies novel susceptibility loci

Meeting Abstract

McMaster, M. L.; Berndt, S. I.; Zhang, J.; Slager, S. L.; Li, S.; Brown, E. E.; Ekstrom-Smedby, K.; Kleinstern, G.; Zhu, B.; Chung, C.; more...
Blood (2017)

Fulltext@MSK | Save

Impact of omitting post-transplant mini-methotrexate doses in allogeneic hematopoietic cell transplantation: A single-center retrospective study

Meeting Abstract

Lin, A.; Hilden, P.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; Tamari, R.; Ponce, D.; Giralt, S. A.; Gyurkocza, B.
Blood (2017)

Fulltext@MSK | Save

Costs and in-hospital mortality rates in autologous stem cell transplant for multiple myeloma: An analysis of the Nationwide Inpatient Sample (NIS) Database

Meeting Abstract

Liu, Y.; Han, H.; Wei, X.; Wang, Q.; He, J.; Shah, G. L.; Giralt, S. A.; Landgren, O.; Lesokhin, A.
Blood (2017)

Fulltext@MSK | Save

Ex vivo T cell-depleted and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival survival: On behalf of the ALWP of the EBMT and the MSKCC

Meeting Abstract

Malard, F.; Labopin, M.; Cho, C.; Blaise, D.; Papadopoulos, E. B.; Passweg, J. R.; O'Reilly, R.; Milpied, N.; Maloy, M.; Volin, L.; more...
Blood (2017)

Fulltext@MSK | Save